您要查找的是不是：
- Use the INR for anticoagulation therapy. 用INR指導抗凝固治療。
- Patients entered the study when their anticoagulation therapy was withdrawn. 當患者的抗凝治療停止后就被納入該研究中。
- Anticoagulation therapy is the basic method and interventional thrombolysis therapy provides a new way. 抗凝治療為首選治療方法，血管內介入溶栓治療協(xié)同抗凝治療可提高療效。
- Objective Research about objective of health education about anticoagulation therapy after heart valves. 目的研究對機械瓣膜置換術(shù)后患者進(jìn)行健康宣教的目的、內容、方法。
- Reduce the likelihood of patient harm associated with the use of anticoagulation therapy. 降低病人使用抗凝血劑治療可能造成的傷害。
- Clinical Study of Introcoronary Stent Implantation with Associated Anticoagulation Therapy in Acute Myocardial Infarction. 冠脈內支架植入術(shù)及聯(lián)合抗凝治療急性心肌梗死的臨床研究。
- Anticoagulation therapy might dissolve formed small thrombus and might be beneficial to prevent dissemination of large thrombus in early time. 結論從血栓發(fā)生時(shí)間和抗凝治療效果來(lái)看,彩超監測應盡早進(jìn)行。
- Hemorrhage and thromboembolism are the most important long-term complications of anticoagulation therapy after mechanical heart valve replacement. 摘要抗凝治療中的出血與栓塞是心臟機械瓣膜置換術(shù)后最重要的遠期并發(fā)癥。
- Conclusion After heart valves replacement mainforce health education especially anticoagulation therapy,content method examination of PT. 結論心臟瓣膜置換術(shù)后要加強健康宣教,著(zhù)重加強抗凝治療的必要性、方法及出院后復查凝血酶原時(shí)間等。
- Early diagnosis and treatment with urokinase infusion and anticoagulation therapy are able to improve the prognosis, as well as the survival rate. 結論肺栓塞的發(fā)病與易患因素密切相關(guān)，早期診斷，盡早溶栓及抗凝治療，可改善預后，提高患者生存率。
- Conclusion Potal anticoagulation therapy is the effective in preventing portal thrombosis after porta-azygous devascularization for portal hypertension. 結論門(mén)靜脈系統抗凝治療是預防門(mén)靜脈高壓癥斷流術(shù)后門(mén)靜脈系血栓形成的有效方法。
- To evaluate retrospectively the care of about 14 cases of intracranial hemorrhage due to impropriate anticoagulation therapy following mechanical heart valve replacement. 摘要回顧性總結我院14例心臟機械瓣膜置換術(shù)后抗凝治療中，因抗凝強度不當導致顱內出血的病例。
- Results We found 1 systematic review, 3 RCTs and 8 prospective cohort studies about anticoagulation therapy and 2 SRs and 1 CCT about thrombolysis therapy. 結果 關(guān)于抗凝治療共檢索到1篇系統評價(jià)、3篇隨機對照試驗及8篇前瞻性隊列研究；
- Objective To discuss the clinical feasibility of low standard oral anticoagulation therapy for the Chinese people,who comefrom,south with implanted mechanical valve. 目的探討中國人(南方)機械瓣置換術(shù)后低標準口服抗凝藥物治療的可行性及其意義。
- Objective To investigate the feasibility and significance of anticoagulation therapy with low intensity in patients after mechanical heart valve replacement in China. 目的探討低標準口服抗凝藥物治療在國人接受心臟人工機械瓣膜置換術(shù)后的臨床可行性及意義。
- Management of patients with AF in clinical practice represents a very low rate of anticoagulation therapy in AF patients in China due to the presumable risk of bleeding. 我國是腦中風(fēng),特別是出血性腦中風(fēng)的高發(fā)國家,所以對于房顫抗凝的臨床決策往往偏保守,造成我國房顫患者抗凝比例很低。
- Con-clu sion Transurethral electrovaporization-ablation of the prostate is suit to higher risk patients including those on anticoagulation therapy because of its advantages as safety,low morbility and evident efficacy. 結論經(jīng)尿道前列腺電汽化切除術(shù)是一種安全性高、并發(fā)癥少、療效確切的新方法,更適合高齡、高危和抗凝治療的BPH患者。
- To study the changes of blood coagulation-fibrinolysis-C protein system in patients of hypertension with acute ischemic cerebrovascular disease (AICVD) after anticoagulation therapy. 目的：研究高血壓急性缺血性腦血管病(AICVD)患者經(jīng)抗凝治療前后凝血、纖溶及蛋白C系統的反應及臨床療效。
- RESULTS &CONCLUSION: With the increased awareness of both practitioners and patients on warfarin,warfarin will play a more active role in oral anticoagulation therapy,and the clinical use... 結果及結論:隨著(zhù)醫生和患者對華法林的認識不斷加深,華法林將在口服抗凝治療中發(fā)揮更加積極的作用;國內對華法林的使用有待更加規范化。
- Instructive exercise therapy is the most effective way in non-interventional therapy, while medicine therapy mainly included antiplatelet therapy, angiotenic therapy and anticoagulation therapy. 有指導的運動(dòng)療法是非介入性治療策略中最有效的方法；藥物治療主要包括抗血小板治療、血管擴張藥物治療、抗凝治療。
